Characterization of vB_Kpn_F48, a newly discovered lytic bacteriophage for Klebsiella pneumoniae of sequence type 101 by Ciacci, Nagaia et al.
viruses
Article
Characterization of vB_Kpn_F48, a Newly Discovered
Lytic Bacteriophage for Klebsiella pneumoniae of
Sequence Type 101
Nagaia Ciacci 1,2, Marco Maria D’Andrea 1,2 , Pasquale Marmo 1 , Elisa Demattè 3,
Francesco Amisano 4, Vincenzo Di Pilato 5, Maurizio Fraziano 1, Pietro Lupetti 6,
Gian Maria Rossolini 5,7 and Maria Cristina Thaller 1,*
1 Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, Italy; nagaia_ciacci@libero.it (N.C.);
marco.dandrea@unisi.it (M.M.D.); pasquale.marmo@uniroma2.it (P.M.); fraziano@bio.uniroma2.it (M.F.)
2 Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy
3 Center for Integrative Biology, CIBIO, University of Trento, 38122 Trento, Italy; elisa.dematte@unitn.it
4 InBioS—Center for Protein Engineering, Department of Life Sciences, University of Liège, Sart-Tilman,
4000 Liège, Belgium; francesco.amisano@doct.uliege.be
5 Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy;
vincenzo.dipilato@unifi.it (V.D.P.); gianmaria.rossolini@unifi.it (G.M.R.)
6 Department of Life Sciences, University of Siena, 53100 Siena, Italy; pietro.lupetti@unisi.it
7 Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, 50134 Florence, Italy
* Correspondence: thaller@uniroma2.it or mcthaller@gmail.com; Tel.: +39-06-72595984
Received: 22 August 2018; Accepted: 7 September 2018; Published: 9 September 2018


Abstract: Resistance to carbapenems in Enterobacteriaceae, including Klebsiella pneumoniae, represents a
major clinical problem given the lack of effective alternative antibiotics. Bacteriophages could provide
a valuable tool to control the dissemination of antibiotic resistant isolates, for the decolonization
of colonized individuals and for treatment purposes. In this work, we have characterized a lytic
bacteriophage, named vB_Kpn_F48, specific for K. pneumoniae isolates belonging to clonal group
101. Phage vB_Kpn_F48 was classified as a member of Myoviridae, order Caudovirales, on the basis
of transmission electron microscopy analysis. Physiological characterization demonstrated that
vB_Kpn_F48 showed a narrow host range, a short latent period, a low burst size and it is highly stable
to both temperature and pH variations. High throughput sequencing and bioinformatics analysis
revealed that the phage is characterized by a 171 Kb dsDNA genome that lacks genes undesirable
for a therapeutic perspective such integrases, antibiotic resistance genes and toxin encoding genes.
Phylogenetic analysis suggests that vB_Kpn_F48 is a T4-like bacteriophage which belongs to a novel
genus within the Tevenvirinae subfamily, which we tentatively named “F48virus”. Considering the
narrow host range, the genomic features and overall physiological parameters phage vB_Kpn_F48
could be a promising candidate to be used alone or in cocktails for phage therapy applications.
Keywords: bacteriophage; Tevenvirinae; Klebsiella pneumoniae carbapenemase (KPC); K. pneumoniae;
sequence type 101; Klebsiella pneumoniae ST101
1. Introduction
The extensive usage of antibiotics has led to the emergence and dissemination of antibiotic
resistant bacteria, with an increasing number of reports in hospital settings of strains showing
multidrug resistant (MDR), extremely drug resistant (XDR), or even pandrug resistant (PDR)
phenotypes [1]. This situation is further complicated by the slow rate of discovery and development
of new antibiotics, with the net result of a progressive reduction of effective therapeutic options for
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the management of serious infections [2,3]. Consequently, antibiotic resistance has become one of the
major public health problems [3,4].
Klebsiella pneumoniae has emerged as one of the most challenging antibiotic-resistant pathogens,
since it can cause a variety of infections (e.g., urinary tract infections, pneumonia, intra-abdominal
infections, surgical site infections, bacteremia) and exhibits a remarkable propensity to acquire MDR
and XDR phenotypes. Indeed, some clonal lineages of K. pneumoniae have acquired resistance
determinants to most antibiotics available for treating these infections, including fluoroquinolones,
aminoglycosides, expanded-spectrum cephalosporins and carbapenems, while retaining a notable
propensity to disseminate in healthcare settings. Typical representatives of these “high-risk clones”
(HiRiCs) include the Clonal Group (CG) 258 strains, which have played a major role in the
dissemination of KPC-type carbapenemases, the CG15 strains, which are the second most prevalent
CG responsible for ≈20% of all outbreaks, and the CG17, CG37, CG101 and CG147 strains [5].
In particular members of CG101, represented by strains of Sequence Type (ST) 101 and related
variants (e.g., ST1789 and ST1633), are wide-spreading in several European and North African
countries [6–17], and differently from other STs, exhibit a notable promiscuity in term of associated
clinically-relevant resistance determinants, such as carbapenemases of the KPC, OXA-48, VIM and
NDM types [6,11,18,19].
Among potential alternatives to conventional antibiotics against resistant pathogens,
bacteriophages are being reconsidered with interest as valuable tools, given their ability to rapidly and
selectively kill specific bacterial clones [20,21].
Here we describe the isolation and characterization of a novel bacteriophage of the Myoviridae
family with a lytic activity specific to K. pneumoniae strains belonging to ST101 and other members
of CG101.
2. Materials and Methods
2.1. Bacterial Host and Culture Conditions
The K. pneumoniae clinical strain 12C47, isolated in 2011 in Italy, was used as host for the isolation
and propagation of the vB_Kpn_F48 bacteriophage. The strain was part of the collection characterized
during the first national survey on carbapenem-resistant Enterobacteriaceae carried out in Italy in
2011, produced the KPC-2 carbapenemase, displayed a MDR phenotype, and was typed as ST101 by
multi-locus sequence typing (MLST) [22].
2.2. Phage Isolation and Purification
Bacteriophage vB_Kpn_F48 was isolated from sewage wastewaters collected at the Florence
Careggi University hospital by using the double-layer overlay technique and K. pneumoniae 12C47 as
the indicator strain, as previously described [23]. Pure bacteriophage suspensions were obtained by
three rounds of single plaque purification and re-infection of exponentially growing 12C47, as reported
elsewhere [24]. Phage titer, expressed in plaque forming units (PFU)/mL, was estimated by the
soft-agar overlay method [23].
2.3. Transmission Electron Microscopy (TEM)
Aliquots of bacteriophages particles preparations were centrifuged at 25,000× g for 1 h and
suspended at ~1012 PFU/mL in SM buffer (10 mM Tris–HCl, pH 7.5; 100 mM NaCl; 10 mM MgSO4).
Samples were processed by negative stain with 2% uranyl acetate and examined by a FEI Tecnai 12
(FEI, Eindhoven, The Netherlands) transmission electron microscope (TEM) fitted with an Osis Morada
2 × 4K CCD camera (Olympus, Shinjuku, Tokyo, Japan).
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2.4. Determination of Bacteriophage Host Range
Host range of phage vB_Kpn_F48 was determined by the spot test technique using 61 previously
characterized K. pneumoniae strains (Table 1), 24 enterobacterial isolates (Klebsiella variicola, n = 4;
Klebsiella quasipneumoniae subsp. quasipneumoniae, n = 2; Klebsiella oxytoca, n = 1; Enterobacter ludwigii,
n = 1; Enterobacter gergoviae, n = 1; Enterobacter sakazakii, n = 1; Serratia marcescens, n = 3; Citrobacter
freundii, n = 1; Providencia stuartii, n = 1; Edwardsiella tarda, n = 1 and Escherichia coli, n = 8), 18 gram
negative non fermenters (Pseudomonas aeruginosa, n = 14; Acinetobacter baumannii, n = 4) and 16 E. coli
isolates obtained from stools of healthy children, as described by Hsu [25]. All strains with the exception
of commensal E. coli were of nosocomial origin, and K. pneumoniae strains were representatives of
clinically relevant and globally diffused clones. Each strain was grown in 5 mL of LB at 37 ◦C with
shaking to an OD600 of 0.5, then centrifuged at 4500× g for 10 min and suspended in 5 mL of SM buffer.
A 0.1 mL volume of the bacterial suspension was mixed with 4.5 mL of molten soft-agar, poured
onto an LB agar (LBA) plate and, after solidification of the agar, 0.01 mL of phage suspension (titer
~107 PFU/mL) were spotted on the overlay. Sensitivity to the vB_Kpn_F48 infection was tentatively
assessed by the observation of a lysis halo at the spot after overnight (ON) incubation at 35 ± 2 ◦C,
and then confirmed by the efficiency of plating (EOP) method as described below.
Table 1. Host spectrum of vB_Kpn_F48 towards K. pneumoniae clinical isolates. For each combination
of sequence type/capsular genotype, the number of tested strains, the deduced capsular type basing
on the wzi sequencing method and the result of the lysis test are reported (- = all strains were not lysed;
+ = all strains were lysed; ND = Not deducible).
No. of Strains a Sequence Type Capsular Genotype b Deduced K-Type Lysis
11 ST101 wzi137 K17 +
2 ST2502 wzi137 K17 +
1 ST11 wzi75 ND -
3 ST14 wzi2 K2 -
2 ST15 wzi24 K24 -
1 ST1633 wzi137 K17 +
1 ST208 wzi35 K35 -
3 ST258 wzi154 ND -
1 ST258 wzi29 K41 -
1 ST1879 wzi154 ND -
6 ST307 wzi173 ND -
1 ST340 wzi50 K15/K17/K50/K51/K52 -
4 ST37 wzi96 K38 -
1 ST42 wzi41 ND -
1 ST45 wzi101 ND -
2 ST512 wzi154 ND -
1 ST540 wzi33 ND -
1 ST554 wzi154 ND -
2 ST641 wzi38 K38 -
1 ST745 wzi154 ND -
1 ST23 wzi1 K1 -
1 ST11 wzi174 ND -
1 ST489 wzi171 ND -
1 ST3 wzi3 K3 -
2 ST16 wzi50 K15/K17/K50/K51/K52 -
2 ST730 wzi356 ND -
1 ST147 wzi64 K14/K64 -
1 ST475 wzi201-like ND -
1 ST25 wzi72 K2 -
1 ST54 wzi14 K14 -
1 ST859 wzi2 K2 -
1 ST66 wzi4 K2 -
1 ST340 wzi19 K19 -
a tested strains were from different hospitals, samples, patients and countries (Italy and Czech Republic) and were
mostly epidemiological unrelated. b capsular genotyping was performed using the wzi method described by Brissè
and colleagues [26].
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2.5. Preparation of High Titer Bacteriophage Suspensions
A large-scale preparation of vB_Kpn_F48 was obtained by the double-layer overlay technique.
Briefly, an ON culture of strain 12C47 was centrifuged at 4500× g for 10 min and the bacterial pellet was
suspended in 1/10 of the starting volume in SM buffer. A 0.1 mL aliquot of bacteriophage preparation
with a titer of 1 × 106 PFU/mL, previously filtered through 0.22 µm filter, was added to 0.2 mL of the
bacterial suspension. After incubation of 20 min at 37 ◦C, the mixture was added to 4.5 mL of molten
soft-agar and plated onto an LBA plate. Following an ON incubation at 37 ◦C, phages were recovered
by adding 5 mL of SM buffer to each plate and incubating for 2 h at room temperature (RT) with gentle
shaking. The soft-agar layer and SM buffer were then scraped and centrifuged at 4500× g for 10 min.
The supernatant was collected, filtered through a 0.22 µm filter and stored at 4 ◦C. For long-term
storage, phage aliquots were maintained in SM buffer supplemented with 25% glycerol at −80 ◦C.
2.6. Efficiency of Plating (EOP)
All K. pneumoniae isolates sensitive to phage vB_Kpn_F48 in the spot test assay (n = 14) were
selected for the determination of EOP as described by Khan Mirzaei and Nilsson [27]. The EOP
was computed as the ratio between PFU/mL on a sensitive strain and PFU/mL on the indicator
strain and then used to rank each strain as “high productive” (EOP ≥ 0.5), “medium productive”
(0.1 ≤ EOP < 0.5), “low productive” (0.001 < EOP < 0.1) or “inefficient” (EOP ≤ 0001). The assay was
performed in triplicate for each combination of bacterial strain/phage dilution and results are reported
as the mean of three observations.
2.7. One-Step Growth Curve
The dynamic change in phage particles number during a replicative cycle was monitored to
determine the latency period, the eclipse period and the burst size of vB_Kpn_F48 as previously
described [28] with minor modifications. Briefly, the host strain 12C47 was grown in aerobic
conditions at 37 ◦C to mid-exponential phase (OD600 = 0.3–0.4, corresponding to≈1–2× 108 CFU/mL).
The culture was then centrifuged at 4000× g for 10 min at 4 ◦C, and suspended in a 1/10 volume of
SM buffer; a 0.1 mL of bacteriophage was then added to 0.9 mL of the bacterial cell suspension to
achieve a Multiplicity of Infection (MOI) of 0.01. Phages were allowed to absorb for 5 min at 37 ◦C in a
water-bath, and then the mixture was centrifuged twice at 13,000× g for 2 min in order to eliminate
the non-absorbed phages. The pellet was then suspended in 1 mL of SM buffer, diluted 1 × 10−3 in
10 mL of LB medium and incubated at 37 ◦C in a water-bath. Two aliquots were taken at 0, 5, 10, 20,
40, 50, 60, 70 and 80 min post-infection. One aliquot was diluted immediately and plated for phage
titration, while the other was treated with 2% chloroform, shaken briefly, set aside for 10 min at RT
and centrifuged. The aqueous phase of the latter aliquot was then titrated to determine intracellular
phage concentrations. Results are reported as the average number of phages released per infected host
cell, and the burst size was computed as the ratio of the final count of released phage particles to the
initial count of infected bacterial cells during the latent period [29]. Experiments were performed in
triplicate and results are reported as the mean of three observations ± SD.
2.8. Influence of Physical Agents on Phage Viability
Stability of vB_Kpn_F48 to different pH values was evaluated by suspending phages at
approximately 107 PFU/mL in aliquots of 1 mL SM buffer, previously adjusted with 1 M NaOH
or 1 M HCl, to yield a pH range from 2.0 to 11.0 with intervals of 1 unit. Phage preparations were
incubated at RT for 60 min. Stability of vB_Kpn_F48 to different temperatures was determined by
incubation of phage preparations (≈107 PFU/mL) at 25 ◦C (control), 40 ◦C, 50 ◦C, 60 ◦C, 65 ◦C and
70 ◦C for 10, 20, 40 and 60 min. In both cases, serial dilutions of each sample were tested against strain
12C47 in a double-layer agar assay to check for the lytic activity of the phage. Assays were performed
in triplicate and the results are reported as the mean of phage counts (PFU/mL) ± SD.
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2.9. Time-Kill Assay
To determine the activity of phage vB_Kpn_F48 against strain 12C47 in vitro, a time-kill assay
was performed using a modified protocol [30]. The indicator strain was grown in 45 mL LB medium at
37 ◦C to OD600 = 0.2 (approximately 0.6 × 108 CFU/mL) and infected with 5 mL phage suspension
at about 5 × 108 PFU/mL (MOI = 1), 5 × 107 PFU/mL (MOI = 0.1) or 5 × 106 PFU/mL (MOI = 0.01).
A non-infected culture of 12C47 was set up as negative control. All samples were incubated at
37 ◦C with shaking, and 1 mL aliquots were collected at 30 min time intervals for 7 h and at 24 h
post-infection. Each aliquot was centrifuged twice at 13,000× g for 2 min in order to eliminate the
nonabsorbed phages and the pellet was then suspended in 1 mL of 0.9% NaCl. Each sample was finally
serially diluted [31] and plated on LBA for enumeration of viable colonies following ON incubation
at 35 ± 2 ◦C. Experiments were performed in triplicate and results are reported as the mean of three
observations ± SD and expressed as log-transformed values (log CFU/mL) over time.
2.10. Rate of Appearance of Phage-Resistant Mutants
The rate of phage-resistant mutant emergence was determined by the method described by
Merabishvili [32] by mixing 1 mL of exponentially growing (~108 CFU/mL) culture of 12C47 with
phage lysate to reach a MOI of 100. After 10 min of incubation at 37 ◦C with shaking, four 10-fold
serial dilutions (101–104) in SM were prepared and 0.1 mL of each dilution was spread on LBA plates.
Colonies were enumerated after overnight incubation at 35 ◦C. A non-infected culture of 12C47 was
set up as negative control. The obtained colonies were isolated twice to assure phage-free bacterial
cultures, and then tested against vB_Kpn_F48 by spot test to confirm their resistance to infection.
2.11. Extraction of Bacteriophage vB_Kpn_F48 DNA
Bacteriophage DNA was extracted from phage lysate with the kit Wizard® DNA Clean-Up System
(Promega, Madison, WI, USA) according to the method described by Gill [33]. Prior to DNA extraction,
DNase (10 µg/mL) and RNase (10 µg/mL) were added to the phage lysate and the sample was
incubated at RT for 2 h. After incubation, 2 volumes of precipitating solution (10% PEG-800, 1 M NaCl)
were added, the mixture was incubated on ice for 1 h, centrifuged at 10,000× g for 10 min at 4 ◦C
and the pellet was re-suspended in 0.5 mL of SM buffer. The obtained pellet was transferred to a new
microcentrifuge tube and centrifuged for 5–10 s to remove any suspended particles. The supernatant
was then transferred to a new tube and used for phage DNA extraction by using the above-mentioned
kit. At the end of the extraction process, DNA samples were dissolved in 0.1 mL of sterile ddH2O
preheated to 80 ◦C and stored at 4 ◦C.
2.12. Genome Sequencing
The genome of vB_Kpn_F48 was sequenced with the MiSeq instrument (Illumina Inc., San Diego,
CA, USA) and a paired-ends approach (2 × 250 bp) by using the kit Illumina Nextera XT™. Direct
Sanger sequencing was performed to determine the 5′- and 3′-ends of the phage genome and to close
gaps occurring between contigs using the primers reported in Table S1.
2.13. Bioinformatics Analysis of Phage Genome
Reads obtained from genome sequencing were assembled using the SPAdes software [34] into
149 nodes. Nodes having a coverage <10×were considered of chromosomal origin or artifacts and thus
removed from the subsequent analysis. A total of 10 nodes were then analyzed by BLASTN software
using the nr database (http://blast.ncbi.nlm.nih.gov/) to remove additional nodes of chromosomal
origin. A total of 8/10 nodes were then retained and ordered by using the characterized phage
Bp7 (Accession number: NC_019500), the closest homolog deposited in the International Nucleotide
Standard Database Collaboration (INSDC) databases, as template. A PCR approach coupled with
Sanger sequencing was employed to verify the order of the nodes and to close gaps. Finally, direct
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Sanger sequencing on whole phage DNA preparations was employed to verify the 5′- and 3′-ends
of the phage genome. A single DNA molecule of 170,764 bp was thus obtained and annotated by
using the Rapid Annotation using Subsystem Technologies (RAST) web-service [35]. The on-line
instance of tRNAScan-SE [36] was used to identify phage tRNA genes, while host tRNA genes
were predicted using ARAGORN [37]. Automatic annotation was manually reviewed by BLASTP
analysis against RefSeq proteins deposited in the INSDC databases. Analysis of conserved protein
domains was performed by using the CD-Search tool [38] and the results were filtered to remove
non-specific hits. Phylogenetic analysis were performed by using the large subunit terminases or
Gp23 protein sequences of bacteriophages of the Tevenvirinae subfamily reported by the International
Committee on Taxonomy of Viruses (ICTV) classification (https://talk.ictvonline.org/taxonomy/;
last accessed 19 April 2018). In both cases closest homologues, i.e., proteins having a ≥85% identity
in a BLAST search (https://blast.ncbi.nlm.nih.gov/), have been also included. Protein alignments
and trees, generated by using the Neighbor Joining method and 1000 bootstraps, were obtained
using ClustalW [39]. Analysis of phage genomes were conducted using the Genome-BLAST Distance
Phylogeny (GBDP) method implemented by the VICTOR webserver, with settings recommended
for prokaryotic viruses [40]. Phage lifestyles were predicted using Phage Classification Tool Set
(PHACTS) [41].
3. Results
3.1. Phage Isolation and Morphological Characterization
The strain 12C47, an ST101 KPC-producing Klebsiella pneumoniae (KPC-Kp) isolated in Italy in
2011, was used as host to investigate the presence of virulent phages in a wastewater sample of
a large tertiary-care teaching hospital located in central Italy, where KPC-Kp have been endemic
since 2009 [22,42]. Results from this experiment revealed the presence of ≈50 clear small plaques
(diameter < 1 mm) all characterized by a similar morphology, suggesting the presence of a single
lytic phage. One plaque was picked up, and used for the propagation of the selected phage,
named vB_Kpn_F48. Results from TEM analysis showed that vB_Kpn_F48 was characterized by
a prolated head, approximately 120 nm × 80 nm, which is connected by an apparent collar to a helical,
contractile tail (≈100 nm long) that ends with a baseplate provided with tail pins and several tail fibers
(Figure 1). These morphological features suggested that vB_Kpn_F48 belongs to the family Myoviridae,
order Caudovirales.
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3.2. Phage Host Range
A total of 103 clinical isolates (61 K. pneumoniae of different clonal lineages and 42 gram negatives
not belonging to the K. pneumoniae species) plus 16 commensal E. coli from healthy children were used
to evaluate the host range of vB_Kpn_F48 (Table 1). Results demonstrated that this phage had a lytic
activity specific to K. pneumoniae strains of ST101 (n = 11) and single locus variants thereof (i.e., ST1633,
n = 1; ST2502, n = 2). All the other tested strains, including K. pneumoniae (n = 47), belonging to different
clonal lineages (i.e., CG258) [43,44], were found to be insensitive to the infection by vB_Kpn_F48.
3.3. EOP of Phage vB_Kpn_F48
The EOP analysis revealed a high productive infection of phage vB_Kpn_F48 for 9 of the 14 strains
sensitive to vB_Kpn_F48 in the spot assay. A medium production has been observed for the isolate
belonging to ST1633, while the remaining four strains resulted in inefficient production (Table 2).
An inefficient production of the phage could be explained either by an abortive infection or a lysis
from without phenomenon, two processes that involve the adsorption of a high number of phage
particles onto the bacterial cell wall and end with the rapid disruption of the bacterial cell-forming
clear zones on a bacterial plate without phage production [45].
Table 2. Efficiency of plating (EOP) for phage vB_Kpn_F48 on K. pneumoniae isolates sensitive to the
phage infection. For each isolate, the strain identifier, the sequence type and the EOP are reported.
Each EOP value is the mean of three observations ± SD. EOP of the original strain of isolation is
marked in bold and the type of phage production is ranked according to Viazis and colleagues [46].
ID Sequence Type EOP Production
12C47 ST101 1 High
12C73 ST101 0.9 ± 0.2 High
KPC174 ST1633 0.44 ± 0.06 Medium
5559 ST101 0.5 ± 0.2 High
5583 ST2502 0 a Inefficient
C002 ST101 1.9 ± 0.7 High
K13 ST101 2.62 ± 0.01 High
K18 ST101 <0.001 b Inefficient
6071 ST2502 0 Inefficient
12C29 ST101 2.2 ± 0.7 High
5546 ST101 3.9 ± 0.3 High
12C72 ST101 3.1 ± 0.3 High
KPC220 ST101 0 Inefficient
494647 ST101 0.9 ± 0.2 High
a EOP = 0 indicates susceptibility to phage infection observed in the spot test but not in the EOP assay. b EOP < 0.001
indicates that the PFU produced by the phage on the target bacterium was more than 1000 times less than those
observed on the indicator strain.
3.4. Latency Period, Eclipse Period and Burst Size Determination
Results from one-step growth experiments showed a triphasic curve indicating that vB_Kpn_F48
was characterized by relatively short eclipse and latency periods (both less than 10 min) followed by a
rise period of 40 min and a growth plateau reached in 40 min (Figure 2). The burst size of vB_Kpn_F48
was computed as 72 phages particles per infected bacteria. The increase in phage titer reported after
one hour of infection represents the beginning of the second replication cycle, and thus data from this
phase were not considered for the burst size computation.
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Figure 2. One-step growth curve of bacteriophage vB_Kpn_F48. The PFU per infected cell at different time points in chloroform-treated 
cultures (blue) and in untreated cultures (orange) are shown. EP: eclipse period; BS: burst size. Each data point is the mean from three 
experiments. Standard deviations are shown as vertical lines. 
Figure 2. One-step growth curve of bacteriophage vB_Kpn_F48. The PFU per infected cell at different
time points in chloroform-treated cultures (blue) and in untreated cultures (orange) are shown.
EP: eclipse period; BS: burst size. Each data point is the mean from three experiments. Standard
deviations are shown as vertical lines.
3.5. Sensitivity to Physical Parameters
Data obtained from stability test vs. temperature variations demonstrated that the infectivity
of vB_Kpn_F48 was overall stable in the range between 25 and 60 ◦C. Conversely, a high decrease
of the infective capacity (~4 log) was observed after incubation at 65 ◦C for 60 min with a complete
inactivation of vB_Kpn_F48 after incubation at 70 ◦C for 10 min (Figure 3). Results of stability test at
different pH values indicated that vB_Kpn_F48 retained the maximum infectivity after incubation at
pH values ranging from 4.0 to 8.0, while a reduction of approximately 40% was detected at pH 2.0
and pH 3.0. A decrease in phage infectivity was also detected at pH 9.0 (25%) and at pH 10.0 (45%).
Anyway, a high phage viability was observed in all the tested conditions (Figure 4).
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3.6. Killing Dynamic of vB_Kpn_F48 against the 12C47 Strain
To evaluate the killing effect of phage vB_Kpn_F48 against the 12C47 strain, liquid cultures of the
bacterial host in the xponential phase wer infected with the phage at three different MOI and cell
number was monitored over time (Figure 5). Data obtained from this assay show d a sigmoid curve
for all conditions charac e ized by a lag phase that is directly correlated w th the MOI. In p rt cular,
lag phases of approximately 1, 2, o 2.5 h were observed by using MOIs of 0.01, 0.1 or 1, respectively.
After 4 h the cultures, at all the tested MOIs, showed a 0.5–1 log re uction i cell count, even if the
reduction of viable cells doesn’t correl te with MOIs, with MOI of 0.01 that resulted in the higher
killing effect. A similar trend, i.e., the absen e of n inverse correla ion between MOI and bacterial
growth, has been previou ly observe and correlated to the ppearance f phage-resistant/persister
bacteria following a random fluctuation model [47,48].
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Figure 5. Time-kill assays with bacterial host in exponential phase. Viable cell count (log CFU/mL) of
12C47 cultures infected with vB_Kpn_F48 at MOI of 1 (blue), MOI of 0.1 (black), MOI of 0.01 (green) and
the uninfected control (red) are shown. Each data point is the mean from three experiments. Standard
deviations are shown as vertical lines.
3.7. Frequency of Emergence of Phage-Resistant Mutants
The frequency of emergence of phage-resistant mutant bacterial cells was estimated to be
1.5 × 10−7 mutants per total cells count for bacteriophage vB_Kpn_F48. This frequency is similar to
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that obtained for other Myoviruses, e.g., phage Acibel004 infecting A. baumannii that showed a mutation
frequency rate of 1.2 × 10−7 mutants per total cells count [32]. Resistant mutants were phenotypically
undistinguishable from parental strain.
3.8. Genome Analysis
Molecular characterization, performed by high-throughput DNA sequencing and Sanger
sequencing for the resolution of the 5′- and 3′-ends and gap closing, revealed that the genome of
vB_Kpn_F48 is composed by a linear dsDNA molecule of 170,764 bp and a GC content of 40.8%.
No repeated terminal sequences were detected at the 5′- and 3′-ends, consistent with other members
of the Myoviridae family. A total of 283 putative coding regions (CDSs) have been detected by RAST
analysis. Most of the predicted CDSs (n = 239, corresponding to 84.4%) are encoded on the same strand.
The shortest CDS encoded a putative protein of 37 amino acid residues (CDS 140), while the longest
encodes a putative protein of 1403 amino acid residues (CDS 156). The majority of predicted CDSs have
an ATG initial codon (n = 261, corresponding to 92.2%), 17 start with GTG (6%), and the remaining five
with TTG (1.8%). A specific putative function (transcriptional factors, structural proteins, enzymes
involved in the replication and degradation of DNA) could be assigned to 120 of 283 deduced proteins
(42.4%), with 21 of 120 (17.5%) showing high sequence identity to proteins described in phages of the
Tevenvirinae subfamily. No specific function was assigned to the remaining 163 CDSs (57.6%; Table S2).
No significant similarity with known antibiotic resistance determinants, virulence or toxin proteins,
or with elements commonly associated with lysogeny (i.e., integrases, repressors and antirepressors)
was revealed. A lytic lifestyle was predicted by PHACTS analysis, and this prediction was also
supported by the presence of the ndd and denB genes whose deduced products shared a high degree of
similarity (73% and 63% respectively) with the correspondent endonucleases encoded by the T4 phage.
A lysozyme-like superfamily domain was detected in three deduced aminoacid sequences (AUO78644,
AUO78846 and AUO78885) which were homologous to the T4 Gpe, Gp25 and Gp5 proteins (85%, 78%
and 79% similarity, respectively). A total of 8 tRNA were detected by the tRNA-SCAN tool, and 7 were
confirmed also by using ARAGORN. Genes encoding tRNAs are organized in a modular fashion,
a feature common among the Caudovirales, and are equally distributed upstream and downstream the
regions flanking ORF 274-ORF 278.
Comparative analysis of whole genome performed against phages deposited in the INSDC
databases revealed that vB_Kpn_F48 is most closely related with the characterized E. coli Bp7
phage (overall nucleotide identity, 52.3%), a member of the Myoviridae family, Tevenvirinae
subfamily [49,50] (Figure 6).
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Figure 6. Comparative analysis between vB_Kpn_F48 and the Bp7 phage. Genetic map was constructed
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are connected by blue areas.
The nucleotide sequence of vB_Kpn_F48 was deposited in the GenBank database under accession
number MG746602.
3.9. Phylogenetic Analysis
Results of BLASTP searches using the large terminase subunit revealed that vB_Kpn_F48 is a
member of Tevenvirinae subfamily of Myoviridae. A phylogenetic tree of large terminase subunits gave
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results highly consistent with the current ICTV taxonomy, but suggested that vB_Kpn_F48 could not be
assigned to any of the known genus (Figure 7). This observation was also confirmed by the analysis of
Gp23 proteins. A phylogenetic analysis of the whole phage genome, performed by using the VICTOR
web service, confirmed these findings, strongly suggesting that vB_Kpn_F48 is a member of a novel
genus of the Tevenvirinae subfamily (Figure S1).
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4. Discussion
The spread of antibiotic-resistant pathogens constitutes a serious matter in the clinical setting,
given the scarcity of available treatment options. In particular, resistance to carbapenems and its
association to MDR phenotypes in Enterobacteriaceae, including K. pneumoniae, is one of the major
clinical challenges.
Among the most diffused HiRiCs of K. pneumoniae, those of CG101 are on the rise. Their propensity
to acquire different clinically relevant resistance determinants, together with the ability to produce
biofilm and several virulence factors are likely key factors for their success [51].
Bacteriophages could provide a valuable tool to control the dissemination of MDR
microorganisms, especially HiRiCs. In addition, bacteriophages could be used for decolonization
purposes, leading to the reduction of the load of specific bacterial clones and thus limiting the chance
of their spreading. Due to their high specificity, phages can avoid also the alteration of the natural
microbiological equilibrium occurring in the human microbiota when conventional antibiotics are
used [52]. These features, together with their capacity to overcome bacterial antibiotic-resistance,
make bacteriophages potential alternatives for clinical applications in infections caused by MDR
bacteria [53,54].
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In this work, we have described a novel lytic bacteriophage characterized by a narrow spectrum
of lytic activity towards isolates of CG101. It is worth noting that K. pneumoniae isolates belonging to
ST101 and variants thereof are spreading not only in Europe, including Italy, but also in other countries
such as Algeria and Malaysia, where hospital outbreaks sustained by K. pneumoniae of ST101 have been
reported [12,13]. To the best of our knowledge, this work represents the first report of a lytic phage
that specifically targets strains of CG101. It is interesting to notice by the EOP test that both strains
of ST2502 (CG101) gave an inefficient production of vB_Kpn_F48, maybe due to a reduced efficiency
of phage recognition based on genetic mutations in this clonal lineage. Furthermore, all strains of
CG101 used in this work were predicted from wzi sequencing to express a K17 serotype [26]. This may
suggest that, differently from E. coli phage T4 that targets lipopolysaccharide or outer membrane
OmpC as receptors [55], the cell structures recognized by vB_Kpn_F48 are components of the capsular
polysaccharide. The lack of strains of the K17 serotype not belonging to CG101 in our collection didn’t
allow to test such a correlation, but genomic analyses of phage resistant mutants are currently ongoing
and will be the subject of future investigations aimed to characterize vB_Kpn_F48 receptors.
Morphological characterization performed by TEM showed that vB_Kpn_F48 is a member of
the family Myoviridae, order Caudovirales. Results of phylogenetic analysis performed using markers
previously employed in several phylogenetic studies of the T4- and T7-like phages [56–59], strongly
suggested that vB_Kpn_F48 is a member of a novel genus of the Tevenvirinae subfamily. This finding is
also supported by the phylogenetic analysis of the whole phage genome which shows a full consistency
of the obtained trees and current ICTV taxonomy, with very high bootstrap values, and again confirmed
that vB_Kpn_F48 forms a distinct clade of the Tevenvirinae subfamily. For these reasons, we propose that
vB_Kpn_F48 represents a new genus within the Tevenvirinae, which we tentatively named “F48viruses”.
Physiological characterization showed that vB_Kpn_F48 is characterized by relatively short latent
and eclipse periods and a low burst size of 72 phage particles released per infected bacteria. The result
is a slight reduction in bacterial cells count over time as highlighted by the killing-curve, with a low
frequency of occurrence of phage-resistant mutant, one of the major important infection parameters
for the therapeutic use of bacteriophages. Results from stability test to physicochemical parameters
demonstrated that vB_Kpn_F48 is exceedingly stable to temperature variations if compared to other
lytic phages of the Myoviridae family targeting K. pneumoniae, e.g., the phage vB_KpnM_KP15 [60]
which showed a 100-fold decrease in titer after 10 min at 60 ◦C. Similar results were obtained for
stability to pH variations. These features, together with the host specificity, its close genetic relatedness
to a well-known group of strictly lytic phages, together with the absence of the genes associated with
lysogeny and the relatively low frequency of occurrence of phage-resistant mutants, make vB_Kpn_F48
an excellent candidate of interest for potential clinical applications [61], such as decontamination,
decolonization and/or therapy. Finally, the presence in vB_Kpn_F48 of several T4-like putative
endonucleases (e.g., Ndd and DenB homologues) suggests that this phage is able to prevent the
“superspreader” effect [62], i.e., the release of intact, transformable plasmid DNA that upon lysis can
be transferred horizontally by transformation, making vB_Kpn_F48 a promising candidate to hinder
the colonization process.
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/10/9/482/s1,
Table S1: Primers used for the vB_Kpn_F48 genome characterization, Table S2: General features of the coding
regions of phage vB_Kpn_F48, Figure S1: Phylogenomic GBDP tree inferred using the formula D4 yielding the
maximum average support of 71% among the three different formulas obtained by the VICTOR web server.
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